Skip to main content

Table 4 Species and treatments

From: Clinical features and risk factors of invasive pulmonary aspergillosis in interstitial lung disease patients

 

IPA group (n = 58)

Positive cultures

 

 Sputum

30/56 (53.6)

 Bronchoalveolar lavage

11/30 (36.7)

Positive NGS in BALF

18/24 (75.0)

Positive NGS in sputum

1/1 (100.0)

Positive Aspergillus antibodies

4/8 (50.0)

Positive GM in serum

19/56 (33.9)

Positive GM in BALF

20/30 (66.7)

Positive PCR

2/2 (100.0)

Species

 

A. fumigatus

23 (39.7)

A. flavus

12 (20.7)

A. niger

3 (5.2)

A. terreus

2 (3.4)

A. fumigatus + A. terreus

1 (1.7)

A. fumigatus + A. flavus

4 (6.9)

A. flavus + A. niger

1 (1.7)

A. fumigatus + A. niger

1 (1.7)

 NA

11 (17.0)

Treatment

 

 Voriconazole

50 (86.2)

 Isavuconazole

7 (12.1)

 Amphotericin B

1 (1.7)